Kirsten Mason, PharmD, BCPS
Regional Clinical Pharmacy Manager
Ascension Texas
Dr. Kirsten Mason is a graduate of the University of Tennessee Health Science Center College of Pharmacy. She completed her PGY1 Pharmacy Residency at Memphis Veterans Affairs Medical Center and her PGY2 Internal Medicine Residency at University Medical Center Brackenridge in Austin, TX. Immediately after residency training, Dr. Mason accepted a clinical pharmacy specialist position in cardiology at Northwestern Memorial Hospital in Chicago. In 2016, she had an opportunity to relocate back to Austin and she joined Dell Seton Medical Center at University of Texas as an Internal Medicine Clinical Pharmacy Specialist. In this role, she assisted in the development of an inpatient opioid use disorder treatment service. In November of 2018, Dr. Mason transitioned roles within Ascension Texas to a Regional Clinical Pharmacy Manager with an emphasis on project management and pain management. She also serves as a preceptor for University of Texas College of Pharmacy and Texas A&M College of Pharmacy. Dr. Mason continues to advocate for treatment of opioid use disorder across the continuum of care and educate healthcare providers about medications for opioid use disorder. More recently, Dr. Mason is serving as Interim Director of Pharmacy at Ascension Seton Northwest.
Disclosure: Dr. Mason has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
- Consultant: Macromoltek Grant Consultant
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.